They further discussed the impaired insulin signaling in AD, which is accompanied by reduced levels of tau, PI3K, Akt, enhanced glycogen synthase kinase-3β, PTEN, and Aβ production (Steen et al., 2005). This evidence concerns the gene MAPT and Alzheimer disease.